Efficacy and mechanism of Baicao Fuyanqing suppository on mixed vaginitis based on 16S rRNA and metabolomics

Frontiers in Cellular and Infection Microbiology

Cellular and Infection Microbiology

Shuo Zhang¹  Nan Jiang²  Qi Wang³  Minyan Yuan³  Pengjiao Wang³  Xiaodong Sun³  Leyuan Shang³  Yujie Liu³  Min Zhang³  Xiuli Gao³  Yanni Zhao³ 

[1] Center of Microbiology and Biochemical Pharmaceutical Engineering, Guizhou Medical University, Guiyang, China;Experimental Animal Center, Guizhou Medical University, Guiyang, China;Research and Development Department, Changsheng Pharmaceutical Co. Ltd., Guizhou, China;State Key Laboratory of Functions and Applications of Medicinal Plants and School of Pharmacy, Guizhou Medical University, Guiyang, China;Center of Microbiology and Biochemical Pharmaceutical Engineering, Guizhou Medical University, Guiyang, China;

关键词: Chinese medicine suppository;    mixed vaginitis;    vaginal flora;    Lactobacillus;    lipid metabolism;   

DOI  :  10.3389/fcimb.2023.1166366

 received in 2023-02-15, accepted in 2023-08-22,  发布年份 2023

来源: Frontiers

【 摘 要 】

BackgroundMixed vaginitis is the infection of the vagina by at least two different pathogens at the same time, both of which contribute to an abnormal vaginal environment leading to signs and symptoms. Baicao Fuyanqing suppository (BCFYQ) is a Miao ethnomedicine, used to treat various vaginitis. The aim of this study was to investigate the efficacy and possible mechanism of BCFYQ in the treatment of mixed vaginitis based on 16S rRNA high-throughput sequencing and metabonomics.MethodsEscherichia coli and Candida albicans were used to establish mixed vaginitis model in SD rats. Three groups of low, medium and high doses (0.18/0.36/0.64 g.kg-1) were established, and administered vaginally once a day for 6 consecutive days. After the last administration, vaginal pH and IL-1β, IL-2, IL-13 and IgA levels were measured, and the vaginal tissue was examined pathologically. In addition, the vaginal flora was characterised by 16S rRNA, and endogenous metabolites in the vaginal tissue were detected by UHPLC-Q-Exactive MS.ResultsCompared with the model group, BCFYQ can reduce the vaginal pH of rats, make it close to the normal group and improve the damaged vaginal epithelial tissue. The results of ELISA showed that BCFYQ decreased the levels of IL-1 β and IL-2 and increased the levels of IL-13 and IgA (P<0.05). In addition, BCFYQ may increase the abundance of vaginal flora, especially Lactobacillus. The differential metabolite enrichment pathway suggests that the therapeutic mechanism of BCFYQ is mainly related to lipid metabolism and amino acid metabolism.ConclusionOur research shows that BCFYQ has a good therapeutic effect on mixed vaginitis. It repairs the damaged vaginal mucosa by regulating the vaginal flora and lipid metabolism disorders to improve the local immune function of the vagina and inhibit the growth and reproduction of pathogens.

【 授权许可】

Unknown   
Copyright © 2023 Wang, Wang, Yuan, Zhang, Zhang, Sun, Shang, Liu, Zhao, Jiang and Gao